DENVER — Early data for a new vaccine for pancreatic cancer is generating some hope among patients, researchers and doctors.

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.

It's still early but a one-size-fits-all vaccine is showing promise in helping stop aggressive pancreatic cancers from coming back. Dr. Pradeep Kumar with Austin Gastroenterology explains what this ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival ...

A new experimental pancreatic cancer vaccine may help stop the disease from coming back. it targets common gene mutations found in about 90% of pancreatic cancers.

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...